Saitama, Japan

Tsuyoshi Nomura

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sysmex Corporation. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tsuyoshi Nomura. Retrieved from https://idiyas.com/inventor/tsuyoshi-nomura-2nvm8puq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tsuyoshi Nomura

Introduction

Tsuyoshi Nomura is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.

Latest Patents

Nomura holds a patent for a monoclonal antibody that reacts with a glycopeptide. This glycopeptide contains a core fucose moiety and at least four contiguous amino acid residues located on the C-terminal side of a glycosylated asparagine moiety. The patent highlights that both the core fucose moiety and an amino acid residue, which is located at least three amino acid residues away from the C-terminal of the glycosylated asparagine moiety, serve as epitopes for the antibody. He has 1 patent registered under his name.

Career Highlights

Nomura is currently employed at Sysmex Corporation, where he continues to advance his research and development efforts. His work at Sysmex Corporation has allowed him to collaborate with other talented professionals in the field.

Collaborations

Some of his notable coworkers include Yuriko Egashira and Koji Fukagawa. Their collective expertise contributes to the innovative environment at Sysmex Corporation.

Conclusion

Tsuyoshi Nomura's contributions to the field of biotechnology through his patent on monoclonal antibodies exemplify the critical role of inventors in advancing medical science. His work not only enhances our understanding of glycopeptides but also paves the way for future innovations in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…